nifedipine has been researched along with neuropeptide y in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (42.86) | 18.7374 |
| 1990's | 14 (40.00) | 18.2507 |
| 2000's | 5 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bolzon, BJ; Cheung, DW; Small, DL | 1 |
| Cervin, A; Lindberg, S; Mercke, U | 1 |
| Gammon, CM; Lyons, SA; Morell, P | 1 |
| Daly, RN; Duesler, JG; Hieble, JP | 1 |
| Huidobro-Toro, JP; Mabe, Y; Tatemoto, K | 1 |
| Bellan, JA; Kadowitz, PJ; Kerstein, MD; MacMillan, LA; McNamara, DB; Minkes, RK | 1 |
| Kaijser, L; Lundberg, JM; Pernow, J | 2 |
| Pernow, J | 1 |
| Lundberg, JM; Pernow, J; Saria, A | 1 |
| Lundberg, JM; Pernow, J | 1 |
| el Din, MM; Malik, KU | 1 |
| Lundberg, JM; Pernow, J; Svenberg, T | 1 |
| Aizawa, Y; Hayashi, M; Satoh, M; Shibata, A; Suzuki, K | 1 |
| Astrand, P; Lundberg, JM; Stjärne, L | 1 |
| Bayorh, MA; Haass, M; Zukowska-Grojec, Z | 1 |
| Dahlöf, C; Franco-Cereceda, A; Lundberg, JM | 1 |
| Anggård, A; Hamberger, B; Lundberg, JM; Pernow, J; Sollevi, A; Theodorsson Norheim, E; Torssell, L | 1 |
| Edvinsson, L; Ekblad, E; Håkanson, R; Wahlestedt, C | 1 |
| Iravani, MM; Zar, MA | 1 |
| Harris, JB; Posangi, J; Zar, MA | 1 |
| Edvinsson, L; Hedner, T; Leppert, J; Myrdal, U; Nilsson, H; Ringqvist, I | 1 |
| Bolzon, BJ; Cheung, DW; Xiong, Z | 1 |
| McCullough, LA; Westfall, TC | 1 |
| Ohtomo, Y; Ono, S; Sahlgren, B; Zettergren, E | 1 |
| Buus, C; Mulvany, MJ; Nilsson, H; Prieto, D | 1 |
| Abdulla, FA; Smith, PA | 1 |
| Brown, N; Cortés, V; Donoso, MV; Fanjul, R; Fournier, A; Huidobro-Toro, JP; López, C | 1 |
| Doods, HN; King, PJ; Widdowson, PS; Williams, G | 1 |
| Bischoff, A; Michel, MC | 1 |
| Adler, EM; Grote, SK; Schwartz, PJ; Stephans, KL | 1 |
| Altobelli, D; Fuxe, K; Martire, M; Maurizi, S; Preziosi, P | 1 |
| Anderson, LL; Glavaski-Joksimovic, A; Jeftinija, K; Jeftinija, S; Scanes, CG | 1 |
| Patz, S; Wahle, P; Wirth, MJ | 1 |
| Fountain, SJ; Gonzalez-Montelongo, MDC | 1 |
1 trial(s) available for nifedipine and neuropeptide y
| Article | Year |
|---|---|
Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
Topics: Administration, Oral; Adult; Blood Pressure; Blood Pressure Determination; Cold Temperature; Drug Administration Schedule; Female; Humans; Middle Aged; Neuropeptide Y; Nifedipine; Norepinephrine; Raynaud Disease; Sympathetic Nervous System | 1993 |
34 other study(ies) available for nifedipine and neuropeptide y
| Article | Year |
|---|---|
Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
Topics: Adenosine Triphosphate; Animals; Arteries; Calcium Channels; Drug Synergism; Endothelium, Vascular; In Vitro Techniques; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Norepinephrine; Potassium Chloride; Rats; Tail; Vasoconstriction | 1992 |
The effect of neuropeptide Y on mucociliary activity in the rabbit maxillary sinus.
Topics: Adrenergic alpha-Antagonists; Animals; Cilia; Dose-Response Relationship, Drug; Female; Male; Maxillary Sinus; Mucous Membrane; Neuropeptide Y; Nifedipine; Rabbits | 1991 |
Modulation by neuropeptides of bradykinin-stimulated second messenger release in dorsal root ganglion neurons.
Topics: Analgesics; Animals; Arachidonic Acid; Arachidonic Acids; Bradykinin; Calcium; Cells, Cultured; Diglycerides; Endorphins; Fetus; Ganglia, Spinal; Kinetics; Models, Biological; Neurons; Neuropeptide Y; Nifedipine; Pertussis Toxin; Rats; Rats, Inbred Strains; Second Messenger Systems; Somatostatin; Verapamil; Virulence Factors, Bordetella | 1990 |
Studies on the mechanism of neuropeptide Y induced potentiation of neurogenic vasoconstriction in the isolated rabbit ear artery.
Topics: Animals; Arteries; Calcium; Cyclooxygenase Inhibitors; Ear; Electric Stimulation; Indomethacin; Infusions, Intra-Arterial; Neuropeptide Y; Nifedipine; Rabbits; Sympathetic Nervous System; Vasoconstriction | 1990 |
Neuropeptide Y-induced pressor responses: activation of a non-adrenergic mechanism, potentiation by reserpine and blockade by nifedipine.
Topics: Angiotensin II; Animals; Blood Pressure; Drug Synergism; Ion Channels; Male; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Phenoxybenzamine; Rats; Rats, Inbred Strains; Reserpine; Tyramine | 1985 |
Analysis of regional responses to endothelin in hindquarters vascular bed of cats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Calcium Channel Blockers; Cats; Endothelins; Endothelium, Vascular; Female; Male; Neuropeptide Y; Nifedipine; Nisoldipine; Peptides; Perfusion; Reference Values; Regional Blood Flow | 1989 |
Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Topics: Adrenal Glands; Adult; Catecholamines; Clonidine; Exercise; Humans; Male; Neuropeptide Y; Nifedipine; Norepinephrine; Phentolamine; Receptors, Adrenergic, alpha; Rest; Sympathetic Nervous System | 1988 |
Characterization of the cardiovascular actions of endothelin in vivo: comparisons with neuropeptide Y and angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Female; Heart Rate; Hemodynamics; Male; Neuropeptide Y; Nifedipine; Nitric Oxide; Renal Circulation; Swine; Vascular Resistance | 1989 |
Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
Topics: Administration, Oral; Adult; Forearm; Humans; Infusions, Intravenous; Male; Neuropeptide Y; Nifedipine; Norepinephrine; Regional Blood Flow; Vasoconstriction | 1989 |
Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Topics: Animals; Basilar Artery; Electric Stimulation; Femoral Artery; Femoral Vein; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Portal Vein; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Sympathetic Nervous System | 1986 |
Neuropeptide Y constricts human skeletal muscle arteries via a nifedipine-sensitive mechanism independent of extracellular calcium?
Topics: Arteries; Calcium Channels; Humans; Mesenteric Veins; Muscle, Smooth, Vascular; Muscles; Neuropeptide Y; Nifedipine; Norepinephrine; Receptors, Nicotinic; Vasoconstrictor Agents | 1986 |
Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcium; Calmodulin; Diltiazem; In Vitro Techniques; Kidney; Male; Neuropeptide Y; Nifedipine; Norepinephrine; Prostaglandins; Rats; Rats, Inbred Strains; Trifluoperazine; Vasoconstriction | 1988 |
Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Topics: Arteries; Female; Humans; In Vitro Techniques; Male; Mesenteric Arteries; Mesenteric Veins; Muscles; Neuropeptide Y; Nifedipine; Norepinephrine; Renal Artery; Vasoconstriction | 1987 |
Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
Topics: Animals; Coronary Circulation; Coronary Vessels; Dogs; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Vascular Resistance; Vasoconstriction | 1986 |
Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study.
Topics: Adenosine Triphosphate; Animals; Electric Stimulation; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Muscle Contraction; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Sympathetic Nervous System; Vas Deferens; Vasoconstrictor Agents | 1986 |
Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats.
Topics: Animals; Blood Pressure; Catecholamines; Heart Rate; Male; Neuropeptide Y; Nifedipine; Norepinephrine; Peptide YY; Peptides; Rats; Rats, Inbred Strains; Regional Blood Flow; Sympathetic Nervous System; Sympatholytics; Vascular Resistance; Vasoconstriction | 1986 |
Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Topics: Animals; Arginine Vasopressin; Atropine; Coronary Vessels; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Metoprolol; Muscle, Smooth, Vascular; Myocardial Contraction; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Phentolamine; Tetrodotoxin | 1985 |
Neuropeptide Y and sympathetic vascular control in man.
Topics: Adult; Animals; Arteries; Blood Pressure; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chromatography, High Pressure Liquid; Electric Stimulation; Female; Heart Rate; Humans; Male; Middle Aged; Neoplasms; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Peripheral Nerves; Swine; Thoracic Surgery; Vascular Resistance | 1985 |
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
Topics: Animals; Drug Synergism; Egtazic Acid; Female; In Vitro Techniques; Male; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Ouabain; Peptide YY; Peptides; Rabbits; Sodium; Vasoconstriction | 1985 |
Neuropeptide Y in rat detrusor and its effect on nerve-mediated and acetylcholine-evoked contractions.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Autonomic Nervous System; Calcium; Electric Stimulation; Immunohistochemistry; In Vitro Techniques; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Neuropeptide Y; Nifedipine; Oxidopamine; Rats; Rats, Wistar; Synaptic Transmission; Urinary Bladder | 1994 |
Palytoxin-induced transmitter release in the autonomic nervous system of the rat.
Topics: Acrylamides; Animals; Autonomic Nervous System; Cnidarian Venoms; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Immunohistochemistry; In Vitro Techniques; Male; Microscopy, Fluorescence; Motor Neurons; Muscle Contraction; Muscle, Smooth; Nerve Endings; Neuropeptide Y; Neurotransmitter Agents; Nifedipine; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Tetrodotoxin; Vas Deferens | 1994 |
Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.
Topics: Animals; Barium; Cadmium; Calcium Channel Agonists; Electrophysiology; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Rats; Rats, Wistar | 1993 |
Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenine; Animals; Calcium Channel Blockers; Calcium Channels; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Enzyme Inhibitors; Imidazoles; Ion Channel Gating; Isoquinolines; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; PC12 Cells; Peptides; Piperazines; Protein Kinase C; Protein Kinases; Protein Synthesis Inhibitors; Rats; Tetradecanoylphorbol Acetate; Thionucleotides | 1996 |
Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cyclic AMP; Enzyme Activation; In Vitro Techniques; Kidney Tubules, Proximal; Male; Neuropeptide Y; Nifedipine; Phosphoprotein Phosphatases; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 1996 |
Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
Topics: 4-Aminopyridine; Acetylcholine; Adenylyl Cyclases; Animals; Charybdotoxin; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dichlororibofuranosylbenzimidazole; Gadolinium; Glyburide; In Vitro Techniques; Isoproterenol; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Potassium Channels; Rats; Rats, Wistar; Thionucleotides | 1997 |
Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Axotomy; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Causalgia; Ganglia, Spinal; GTP-Binding Proteins; Male; Neurons, Afferent; Neuropeptide Y; Nifedipine; Norepinephrine; omega-Conotoxin GVIA; Patch-Clamp Techniques; Peptide Fragments; Peptide YY; Peptides; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sciatic Nerve | 1999 |
Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Topics: Animals; Arginine; Dinoprost; Drug Synergism; Endothelin-1; Endothelium, Vascular; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Norepinephrine; Peptide Fragments; Potassium Chloride; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Serotonin; Vasoconstriction | 1999 |
Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
Topics: Agatoxins; Animals; Arginine; Autoreceptors; Biological Transport; Calcium Channel Blockers; Hypothalamus; Ligands; Male; Naphthalenes; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; omega-Conotoxins; Organ Culture Techniques; Peptide Fragments; Peptides; Peptides, Cyclic; Potassium; Pyrimidines; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Spider Venoms | 1999 |
Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
Topics: Aldosterone; Animals; Bradykinin; Humans; Indomethacin; Losartan; Male; Neuropeptide Y; Nifedipine; Potassium; Rats; Rats, Wistar; Sodium | 2000 |
Zinc elevates neuropeptide Y levels in rat pheochromocytoma cells by a mechanism independent of L-channel mediated inhibition of release.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Neurites; Neuropeptide Y; Nifedipine; PC12 Cells; Rats; Zinc | 2000 |
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Topics: Animals; Aspartic Acid; Baclofen; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Ion Channel Gating; Male; Nerve Endings; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; Peptide Fragments; Potassium; Protein Isoforms; Rats; Rats, Wistar; Spinal Cord; Stereoisomerism; Synaptosomes | 2000 |
Stimulatory effect of ghrelin on isolated porcine somatotropes.
Topics: Adenylyl Cyclase Inhibitors; Animals; Animals, Newborn; Benzazepines; Calcium; Calcium Channels, L-Type; Cell Culture Techniques; Dose-Response Relationship, Drug; Ghrelin; Growth Hormone; Growth Hormone-Releasing Hormone; Immunohistochemistry; Neuropeptide Y; Nifedipine; Peptide Hormones; Pituitary Gland; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Signal Transduction; Sodium Channels; Somatostatin; Swine; Tetrazoles; Type C Phospholipases | 2003 |
Transcellular induction of neuropeptide Y expression by NT4 and BDNF.
Topics: Animals; Brain-Derived Neurotrophic Factor; Calcium; Cerebral Cortex; Gene Expression Regulation; Nerve Growth Factors; Neuropeptide Y; Nifedipine; Protein-Tyrosine Kinases; Rats; Rats, Long-Evans; Signal Transduction | 2005 |
Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Animals; Benzenesulfonates; Calcium Channel Blockers; Calcium Channels, L-Type; Male; Mesenteric Arteries; Mice, Inbred C57BL; Neuropeptide Y; Nifedipine; Prazosin; Receptors, Neuropeptide Y; Receptors, Purinergic P2X1; Suramin; Sympathetic Nervous System; Vasoconstriction | 2021 |